Preliminary analysis of one-year progression-free survival data from Phase 2 study of novel SST2 agonist paltusotine under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback